Surgery Viable for Advanced Prostate Cancer, Study Finds

After removal of their prostate gland, 80% of patients survived 20 years

TUESDAY, May 17 (HealthDay News) -- Surgery to remove the prostate gland (radical prostatectomy) led to a 20-year survival rate for 80 percent of patients with advanced prostate cancer, a new study finds.

The study included patients with cancer that had spread beyond the prostate, known as cT3 prostate cancer, and underwent radical prostatectomy between 1987 and 1997.

The 80 percent survival rate in these patients compares to a 90 percent survival rate at 20 years for patients with cancer confined to the prostate (cT2 prostate cancer), the Mayo Clinic researchers said.

Previously, patients with cT3 prostate cancer were offered radiation or hormone treatment, but not radical prostatectomy, the study authors noted in a Mayo news release.

"We are doing a much better job of identifying and expanding candidates for surgery, which results in better, longer outcomes for so many of our patients," Dr. R. Jeffrey Karnes, of the department of urology, said in the news release.

The study was slated for presentation May 15 at the annual meeting of the American Urological Association, in Washington, D.C. Research presented at meetings is considered preliminary until it is published in a peer-reviewed journal.

More information

The American Cancer Society has more about prostate cancer.

Robert Preidt SOURCE: Mayo Clinic, news release, May 15, 2011

Related Articles

Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.

Health News is provided as a service to Sharp Web site users by HealthDay. Sharp HealthCare nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please read the Terms of Use for more information.